abstract |
Pharmaceutically-active BHT-omega pyridyl ethers of the formula selected from BHT-omega-pyridyl ether compounds of formula (I) wherein -3-Pyr = (a), wherein m = 1,3, for m = 1, Σ = 6 - 9, for m = 3, Σ = 5 - 11, Sum (Σ) = [m+n+1 (for oxygen)] wherein the bond between the two carbon atoms of the (CHp)n moiety most closely adjacent the pyridine ring is a single, double, or triple bond, and p is 0, 1 or 2, depending on the type of bond, and pharmaceutically-acceptable acid addition salts thereof, pharmaceutical compositions thereof, and a method of combating lipidemia and atherosclerosis therewith, are disclosed. |